Characteristics of cerebral sinus venous thrombosis in men

被引:3
|
作者
Simaan, Naaem [1 ]
Filioglo, Andrei [1 ]
Honig, Asaf [1 ]
Aladdin, Shorooq [1 ]
Cohen, Jose E. [2 ]
Leker, Ronen R. [1 ]
机构
[1] Hadassah Hebrew Univ, Med Ctr, Dept Neurol, POB 12000, IL-91120 Jerusalem, Israel
[2] Hadassah Hebrew Univ, Med Ctr, Dept Neurosurg, Jerusalem, Israel
来源
ACTA NEUROLOGICA SCANDINAVICA | 2021年 / 144卷 / 03期
关键词
aetiology; Behcet' s disease; cerebral sinus venous thrombosis; males; malignancies; BEHCETS-DISEASE; VEIN-THROMBOSIS; RISK; INVOLVEMENT; MANAGEMENT;
D O I
10.1111/ane.13454
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives Cerebral sinus venous thrombosis (CSVT) is a rare stroke subtype that is more common in women, yet data regarding sex-specific characteristics are sparse. We aimed to study male-specific characteristics among patients with CSVT. Materials & methods Data of consecutive patients with CSVT, admitted to a single medical centre between 2005 and 2020, were retrospectively studied. Demographics, clinical presentations, radiological and outcome parameters were compared between male and female patients. Male patients were further divided into older and younger than 35 years old for additional comparisons. Results Out of 15,224 patients diagnosed with stroke, 150 patients (1%) presented with CSVT and 47 (31.3%) of them were males. Males had significantly higher rates of previous thrombotic events (22% vs. 7%, p = .009), malignancies (32% vs. 16%, p = .022) and Behcet's disease (22% vs. 2%, p < .001). Additionally, we found that malignancies were significantly more prevalent in older males (48% vs. 17%, p = .022), while Behcet's disease was more often found in younger patients (35% vs. 9%, p = .032). Additional age-related differences in disease characteristics among male patients included a higher frequencies of papilledema (42% vs. 13%, p = .028), and cortical vein thromboses (21% vs. 0% p = .021) observed in the younger men. Conclusions There are important differences in risk factors for thrombosis between men and women with CSVT. Behcet's disease is common in younger men, while malignancies are major causes of CSVT in older men.
引用
收藏
页码:317 / 324
页数:8
相关论文
共 50 条
  • [21] Cerebral Venous Sinus Thrombosis
    Yadollahikhales, Golnaz
    Borhani-Haghighi, Afshin
    Safari, Anahid
    Wasay, Mohammad
    Edgell, Randall
    GALEN MEDICAL JOURNAL, 2016, 5 : 48 - 61
  • [22] Cerebral venous sinus thrombosis
    Sriram, Nisha
    Saifee, Tabish A.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2017, 78 (07) : C98 - C102
  • [23] Cerebral venous and sinus thrombosis
    Gyuris Jeno
    IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2014, 67 (7-8): : 272 - 275
  • [24] Cerebral venous and sinus thrombosis
    F. Masuhr
    S. Mehraein
    K. Einhäupl
    Journal of Neurology, 2004, 251 : 11 - 23
  • [25] Cerebral venous sinus thrombosis
    Capecchi, M.
    Abbattista, M.
    Martinelli, I.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2018, 16 (10) : 1918 - 1931
  • [26] Cerebral venous impairment and cerebral venous sinus thrombosis
    Wang, Jiaqi
    Manaenko, Anatol
    Hu, Qin
    Zhang, Xiaohua
    BRAIN HEMORRHAGES, 2024, 5 (03): : 131 - 142
  • [27] Commentary: Characteristics and Outcomes of Children with Cerebral Sinus Venous Thrombosis
    Giulia M. Benedetti
    Mark S. Wainwright
    Neurocritical Care, 2023, 39 : 306 - 308
  • [28] Commentary: Characteristics and Outcomes of Children with Cerebral Sinus Venous Thrombosis
    Benedetti, Giulia M.
    Wainwright, Mark S.
    NEUROCRITICAL CARE, 2023, 39 (02) : 306 - 308
  • [29] Characteristics of Cerebral Venous Sinus Thrombosis Due to Autoimmune Diseases
    Saridas, Furkan
    Mesut, Gizem
    Dinc, Yasemin
    Koc, Emine Rabia
    Ozpar, Rifat
    Hakyemez, Bahattin
    Turan, Omer Faruk
    NEUROLOGIST, 2024, 29 (03) : 152 - 157
  • [30] Dehydration in cerebral venous sinus thrombosis
    Ding, Jiayue
    Lan, Duo
    Zhang, Xiaoming
    Li, Xiangyu
    Duan, Yanli
    Tian, Xiaobing
    Liao, Zhangyuan
    Yue, Xuanye
    Zou, Ming
    Meng, Ran
    CNS NEUROSCIENCE & THERAPEUTICS, 2024, 30 (05)